Amphastar Pharmaceuticals, Inc.
AMPH
$17.50
-$0.95-5.15%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 79.23M | 98.09M | 111.63M | 134.71M | 141.63M |
| Total Depreciation and Amortization | 64.49M | 63.20M | 61.88M | 60.54M | 58.45M |
| Total Amortization of Deferred Charges | 3.35M | 3.36M | 3.21M | 3.07M | 4.67M |
| Total Other Non-Cash Items | 55.76M | 57.44M | 7.39M | 12.49M | 12.43M |
| Change in Net Operating Assets | -33.95M | -65.97M | -31.83M | -51.16M | -24.00M |
| Cash from Operations | 168.88M | 156.12M | 152.28M | 159.66M | 193.17M |
| Capital Expenditure | -33.69M | -34.88M | -39.02M | -47.47M | -42.95M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | -129.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -63.85M | -35.45M | -6.42M | -12.94M | 42.26M |
| Cash from Investing | -97.55M | -70.33M | -45.44M | -60.41M | -129.69M |
| Total Debt Issued | 4.57M | 6.22M | 10.81M | 20.15M | 15.99M |
| Total Debt Repaid | -214.00K | -223.00K | -234.00K | -231.00K | -8.20M |
| Issuance of Common Stock | 2.86M | 2.86M | 873.00K | 494.00K | -- |
| Repurchase of Common Stock | -90.08M | -75.59M | -93.69M | -120.53M | -88.68M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -265.00K | -687.00K | -657.00K | -1.24M | -986.00K |
| Cash from Financing | -83.13M | -67.43M | -82.89M | -101.36M | -81.88M |
| Foreign Exchange rate Adjustments | -46.00K | 210.00K | 208.00K | 186.00K | 25.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.84M | 18.57M | 24.15M | -1.93M | -18.37M |